Helena A. Yu MD

Dr. Helena A. Yu is an Associate Professor and Research Director of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center. Her research focuses on clinical and translational work within EGFR-mutant lung cancers. She has a particular research interest in biology and the management of CNS metastases.

Dr. Yu has a special interest in the development of novel targeted therapies for the treatment of lung cancer. She has co-authored >100 peer-reviewed publications, of which several focus on EGFR mutations in non-small cell lung cancer. Dr. Yu oversees the clinical research program for patients with EGFR-mutant lung cancer at the Memorial Sloan Kettering Cancer Center. Dr. Yu has practiced medicine for >16 years and has been the principal investigator on >20 studies.

In 2021, Dr. Yu received an NCI R01 as well as the EGFR Resisters/LUNGevity Lung Cancer Research award for her work on the molecular characterization of lineage plasticity. Her Board Certifications include Internal Medicine and Medical Oncology, and she completed her residency in internal medicine at the Hospital of the University of Pennsylvania. Dr. Yu received her MD from the University of Michigan Medical School and is dedicated to creating comprehensive treatment plans tailored to patient needs and goals.